查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1760539

2025年癌症基因体学及分析全球市场报告

Genomic Cancer Panel And Profiling Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年，基因组癌症检测组和分析市场规模将强劲成长。预计到 2029 年，该市场规模将达到 143.7 亿美元，复合年增长率为 8.7%。预测期内的成长动力包括液态切片的应用范围不断扩大、早期检测的使用日益增多、定制疗法的持续增长以及伴随诊断核准数量的增加。预测期内的主要趋势包括整合人工智慧和机器学习用于基因组数据解释、多体学方法的开发、云端基础的基因组数据储存和分析、与电子健康记录的整合以及次世代定序仪(NGS) 平台的扩展。

癌症发生率的上升预计将推动基因组癌症检测组和分析市场的成长。癌症是一种以体内异常细胞不受控制地增生和扩散为特征的疾病。癌症发生率的上升主要是由于老化等因素，随着人们寿命的延长，老化会增加罹患癌症的风险。基因组癌症检测组和分析用于识别基因突变和生物标记物，以促进个人化治疗计划并改善早期发现和疾病监测。例如，2024 年 1 月，美国癌症协会报告称，2022 年全球约有 2,000 万新诊断出癌症病例，970 万人死亡。随着人口的增长，预计到 2050 年全球癌症患者人数将增加至 3,500 万人。因此，癌症发生率的上升可能会推动基因组癌症检测组和分析市场的成长。

癌症基因组学检测组和分析市场的主要企业正专注于次世代定序仪等技术创新，以提高癌症诊断的准确性、速度和全面性。次世代定序仪是一种先进的DNA序列测定技术，能够快速、高通量地分析遗传物质，以识别基因突变和其他基因组特征。例如，2025年4月，荷兰生技公司QIAGEN NV推出了专为次世代定序仪设计的QIAseq检测组。这些检测组透过分析700多个基因，实现全面的基因组分析，旨在用于研究和临床应用，以改善癌症的诊断和治疗策略。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球基因组癌症小组和分析 PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球基因组癌症面板和分析市场：成长率分析
  • 全球基因组癌症检测组合与分析市场表现：规模与成长，2019-2024 年
  • 全球基因组癌症面板和分析市场预测：规模与成长，2024-2029 年，2034 年
  • 全球基因组癌症面板和分析总目标市场（TAM）

第六章市场区隔

  • 全球基因组癌症检测组合及分析市场（依组织检测、绩效及预测）2019-2024、2024-2029、2034
  • 固态组织检查
  • 液体组织检测
  • 全球基因组癌症面板和分析市场（按技术、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 次世代定序（NGS）
  • 聚合酵素链锁反应（PCR）
  • 萤光原位杂合技术（FISH）
  • 免疫组织化学（IHC）
  • 其他技术
  • 全球基因组癌症面板和分析市场（按癌症面板类型、表现和预测），2019-2024 年、2024-2029 年、2034 年
  • 单基因面板
  • 多基因面板
  • 全球基因组癌症面板和分析市场的应用、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 临床
  • 研究
  • 全球基因组癌症面板和分析市场（按最终用户、绩效和预测）2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 研究和学术机构
  • 临床和诊断实验室
  • 其他最终用户
  • 全球基因组癌症面板及分析市场，依固态组织检验类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 切片检查样本
  • 手术切除样本
  • 福马林固定石蜡包埋（FFPE）组织
  • 新鲜冷冻组织
  • 全球基因组癌症检测组合及分析市场，依液体组织检测类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 血
  • 尿
  • 唾液
  • 脑脊髓液（CSF）
  • 其他体液

第七章 区域和国家分析

  • 基因组癌症面板与分析市场：全球、各地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球基因组癌症面板和分析市场（按国家/地区、绩效和预测）2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 基因组癌症面板和分析市场：竞争格局
  • 基因组癌症检测与分析市场：公司简介
    • Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Sysmex Corporation
  • QIAGEN NV
  • Exact Sciences Corporation
  • ARUP Laboratories
  • Tempus Labs
  • Genscript Biotech Corporation
  • NeoGenomics Inc.
  • Foundation Medicine
  • Invitae Corporation
  • Guardant Health Inc.
  • Caris Life Sciences
  • Fulgent Genetics
  • NanoString Technologies Inc.
  • Genecast Biotechnology Co. Ltd
  • Burning Rock DX

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029 年癌症基因体学及分析市场：提供新机会的国家
  • 2029 年癌症基因组学面板和分析市场：细分市场带来新机会
  • 2029 年癌症基因体学检测及分析市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r35416

Genomic cancer panel and profiling is a molecular diagnostic technique that simultaneously analyzes multiple genes to detect genetic mutations, alterations, or biomarkers linked to cancer. Its primary purpose is to guide personalized treatment decisions, predict disease progression, and enhance cancer diagnosis and monitoring.

The main tissue testing types in the genomic cancer panel and profiling market are solid tissue testing and liquid tissue testing. Solid tissue testing involves analyzing samples from solid tumors or organs to identify genetic mutations, biomarkers, or disease characteristics. Various technologies are employed in this process, including next-generation sequencing (NGS), polymerase chain reaction (PCR), fluorescence in-situ hybridization (FISH), immunohistochemistry (IHC), and others. Cancer panels used in this testing include both single-gene and multi-gene panels. These tests are applied in clinical and research settings, serving end users such as hospitals, research and academic institutes, clinical and diagnostic laboratories, among others.

The genomic cancer panel and profiling market research report is one of a series of new reports from The Business Research Company that provides genomic cancer panel and profiling market statistics, including the genomic cancer panel and profiling industry global market size, regional shares, competitors with the genomic cancer panel and profiling market share, detailed genomic cancer panel and profiling market segments, market trends, and opportunities, and any further data you may need to thrive in the genomic cancer panel and profiling industry. This genomic cancer panel and profiling market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The genomic cancer panel and profiling market size has grown strongly in recent years. It will grow from $9.47 billion in 2024 to $10.31 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. Growth during the historic period can be attributed to the rising global cancer burden, increased use in clinical trials, expansion of diagnostic infrastructure, growing awareness of genetic testing, and increased government and research funding.

The genomic cancer panel and profiling market size is expected to see strong growth in the next few years. It will grow to $14.37 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. Growth in the forecast period is expected to be driven by the expansion of liquid biopsy applications, growing use in early detection, the continued growth in tailored therapies, and an increase in companion diagnostics approvals. Key trends in the forecast period include the integration of AI and machine learning for genomic data interpretation, the development of multi-omics approaches, cloud-based genomic data storage and analysis, integration with electronic health records, and the expansion of next-generation sequencing (NGS) platforms.

The increasing incidence of cancer is expected to drive the growth of the genomic cancer panel and profiling market. Cancer is a disease characterized by the uncontrolled growth and spread of abnormal cells in the body. The rising cancer incidence is primarily due to factors such as an aging population, which increases the risk of cancer as people live longer. Genomic cancer panels and profiling are used to identify genetic mutations and biomarkers, facilitating personalized treatment plans and improving early detection and disease monitoring. For example, in January 2024, the American Cancer Society reported that approximately 20 million new cancer cases were diagnosed globally in 2022, resulting in 9.7 million deaths. With population growth, the global cancer burden is projected to rise to 35 million cases by 2050. Therefore, the increasing incidence of cancer will drive the growth of the genomic cancer panel and profiling market.

Major companies in the genomic cancer panel and profiling market are focusing on technological innovations, such as next-generation sequencers, which enhance the accuracy, speed, and comprehensiveness of cancer diagnostics. Next-generation sequencers are advanced DNA sequencing technologies that allow for rapid, high-throughput analysis of genetic material to identify mutations and other genomic features. For instance, in April 2025, QIAGEN N.V., a Netherlands-based biotechnology company, launched QIAseq panels designed for next-generation sequencers. These panels enable comprehensive genomic profiling by analyzing over 700 genes, targeting both research and clinical applications to improve cancer diagnostics and treatment strategies.

In June 2023, Quest Diagnostics, a US-based clinical laboratory company, acquired Haystack Oncology, a biotech firm specializing in liquid biopsy technologies for early cancer detection and monitoring. The acquisition expands Quest Diagnostics' capabilities in liquid biopsy and cancer detection, enhancing its genomic testing offerings.

Major players in the genomic cancer panel and profiling market are Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Hologic Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, ARUP Laboratories, Tempus Labs, Genscript Biotech Corporation, NeoGenomics Inc., Foundation Medicine, Invitae Corporation, Guardant Health Inc., Caris Life Sciences, Fulgent Genetics, NanoString Technologies Inc., Genecast Biotechnology Co. Ltd, Burning Rock DX, HTG Molecular Diagnostics Inc., and Predictive Oncology Inc.

North America was the largest region in the genomic cancer panel and profiling market in 2024. The regions covered in genomic cancer panel and profiling report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the genomic cancer panel and profiling market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The genomic cancer panel and profiling market consists of revenues earned by entities by providing services such as genetic mutation analysis, companion diagnostic testing, cancer risk assessment, and screening. The market value includes the value of related goods sold by the service provider or included within the service offering. The genomic cancer panel and profiling market also includes sales of targeted gene panels, companion diagnostic kits, sequencing platforms and instruments, bioinformatics software, and analysis tools. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Genomic Cancer Panel And Profiling Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on genomic cancer panel and profiling market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for genomic cancer panel and profiling ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The genomic cancer panel and profiling market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Tissue Testing: Solid Tissue Testing; Liquid Tissue Testing
  • 2) By Technology: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); Fluorescence In-Situ Hybridization (FISH); Immunohistochemistry (IHC); Other Technologies
  • 3) By Cancer Panel Type: Single-Gene Panel; Multi-Gene Panel
  • 4) By Application: Clinical; Research
  • 5) By End User: Hospitals; Research And Academic Institutes; Clinical And Diagnostic Laboratories; Other End Users
  • Subsegments:
  • 1) By Solid Tissue Testing: Biopsy Samples; Surgical Resection Samples; Formalin-Fixed Paraffin-Embedded (FFPE) Tissues; Fresh Frozen Tissues
  • 2) By Liquid Tissue Testing: Blood; Urine; Saliva; Cerebrospinal Fluid (CSF); Other Bodily Fluids
  • Companies Mentioned: Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc.; Agilent Technologies Inc.; Hologic Inc.; Illumina Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Genomic Cancer Panel And Profiling Market Characteristics

3. Genomic Cancer Panel And Profiling Market Trends And Strategies

4. Genomic Cancer Panel And Profiling Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Genomic Cancer Panel And Profiling Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Genomic Cancer Panel And Profiling PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Genomic Cancer Panel And Profiling Market Growth Rate Analysis
  • 5.4. Global Genomic Cancer Panel And Profiling Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Genomic Cancer Panel And Profiling Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Genomic Cancer Panel And Profiling Total Addressable Market (TAM)

6. Genomic Cancer Panel And Profiling Market Segmentation

  • 6.1. Global Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Solid Tissue Testing
  • Liquid Tissue Testing
  • 6.2. Global Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Fluorescence In-Situ Hybridization (FISH)
  • Immunohistochemistry (IHC)
  • Other Technologies
  • 6.3. Global Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Gene Panel
  • Multi-Gene Panel
  • 6.4. Global Genomic Cancer Panel And Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Clinical
  • Research
  • 6.5. Global Genomic Cancer Panel And Profiling Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Research And Academic Institutes
  • Clinical And Diagnostic Laboratories
  • Other End Users
  • 6.6. Global Genomic Cancer Panel And Profiling Market, Sub-Segmentation Of Solid Tissue Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biopsy Samples
  • Surgical Resection Samples
  • Formalin-Fixed Paraffin-Embedded (FFPE) Tissues
  • Fresh Frozen Tissues
  • 6.7. Global Genomic Cancer Panel And Profiling Market, Sub-Segmentation Of Liquid Tissue Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood
  • Urine
  • Saliva
  • Cerebrospinal Fluid (CSF)
  • Other Bodily Fluids

7. Genomic Cancer Panel And Profiling Market Regional And Country Analysis

  • 7.1. Global Genomic Cancer Panel And Profiling Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Genomic Cancer Panel And Profiling Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Genomic Cancer Panel And Profiling Market

  • 8.1. Asia-Pacific Genomic Cancer Panel And Profiling Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Genomic Cancer Panel And Profiling Market

  • 9.1. China Genomic Cancer Panel And Profiling Market Overview
  • 9.2. China Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Genomic Cancer Panel And Profiling Market

  • 10.1. India Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Genomic Cancer Panel And Profiling Market

  • 11.1. Japan Genomic Cancer Panel And Profiling Market Overview
  • 11.2. Japan Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Genomic Cancer Panel And Profiling Market

  • 12.1. Australia Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Genomic Cancer Panel And Profiling Market

  • 13.1. Indonesia Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Genomic Cancer Panel And Profiling Market

  • 14.1. South Korea Genomic Cancer Panel And Profiling Market Overview
  • 14.2. South Korea Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Genomic Cancer Panel And Profiling Market

  • 15.1. Western Europe Genomic Cancer Panel And Profiling Market Overview
  • 15.2. Western Europe Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Genomic Cancer Panel And Profiling Market

  • 16.1. UK Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Genomic Cancer Panel And Profiling Market

  • 17.1. Germany Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Genomic Cancer Panel And Profiling Market

  • 18.1. France Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Genomic Cancer Panel And Profiling Market

  • 19.1. Italy Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Genomic Cancer Panel And Profiling Market

  • 20.1. Spain Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Genomic Cancer Panel And Profiling Market

  • 21.1. Eastern Europe Genomic Cancer Panel And Profiling Market Overview
  • 21.2. Eastern Europe Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Genomic Cancer Panel And Profiling Market

  • 22.1. Russia Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Genomic Cancer Panel And Profiling Market

  • 23.1. North America Genomic Cancer Panel And Profiling Market Overview
  • 23.2. North America Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Genomic Cancer Panel And Profiling Market

  • 24.1. USA Genomic Cancer Panel And Profiling Market Overview
  • 24.2. USA Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Genomic Cancer Panel And Profiling Market

  • 25.1. Canada Genomic Cancer Panel And Profiling Market Overview
  • 25.2. Canada Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Genomic Cancer Panel And Profiling Market

  • 26.1. South America Genomic Cancer Panel And Profiling Market Overview
  • 26.2. South America Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Genomic Cancer Panel And Profiling Market

  • 27.1. Brazil Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Genomic Cancer Panel And Profiling Market

  • 28.1. Middle East Genomic Cancer Panel And Profiling Market Overview
  • 28.2. Middle East Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Genomic Cancer Panel And Profiling Market

  • 29.1. Africa Genomic Cancer Panel And Profiling Market Overview
  • 29.2. Africa Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Genomic Cancer Panel And Profiling Market Competitive Landscape And Company Profiles

  • 30.1. Genomic Cancer Panel And Profiling Market Competitive Landscape
  • 30.2. Genomic Cancer Panel And Profiling Market Company Profiles
    • 30.2.1. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Genomic Cancer Panel And Profiling Market Other Major And Innovative Companies

  • 31.1. Sysmex Corporation
  • 31.2. QIAGEN N.V.
  • 31.3. Exact Sciences Corporation
  • 31.4. ARUP Laboratories
  • 31.5. Tempus Labs
  • 31.6. Genscript Biotech Corporation
  • 31.7. NeoGenomics Inc.
  • 31.8. Foundation Medicine
  • 31.9. Invitae Corporation
  • 31.10. Guardant Health Inc.
  • 31.11. Caris Life Sciences
  • 31.12. Fulgent Genetics
  • 31.13. NanoString Technologies Inc.
  • 31.14. Genecast Biotechnology Co. Ltd
  • 31.15. Burning Rock DX

32. Global Genomic Cancer Panel And Profiling Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Genomic Cancer Panel And Profiling Market

34. Recent Developments In The Genomic Cancer Panel And Profiling Market

35. Genomic Cancer Panel And Profiling Market High Potential Countries, Segments and Strategies

  • 35.1 Genomic Cancer Panel And Profiling Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Genomic Cancer Panel And Profiling Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Genomic Cancer Panel And Profiling Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer